92454 ⎘
Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton Amines containing three or more amino groups bound to the carbon skeleton
POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS
#2METHODS FOR STABILIZING WATER SENSITIVE CLAYS AND MIGRATING FINES IN SUBTERRANEAN FORMATIONS
#3RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION
#4COMPOSITIONS AND METHODS FOR CARBON DIOXIDE CAPTURE
#53-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS
#6STABILIZATION OF PROTEINS WITH CYCLODEXTRINS
#7Methods for stabilizing water sensitive clays and migrating fines in subterranean formations
#8CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
#9Method for Scavenging Airborne Formaldehyde
#10Synthesis of triethylenetetramines
#113-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors
#12Compositions and methods for carbon dioxide capture
#13Nitrogen-containing ligands and their use in atomic layer deposition methods
#14Compositions, methods, and devices for capturing phosphate from water
#15Compositions and methods for stabilizing water sensitive clays and migrating fines in subterranean formations
#16Functional copper sulfide composition and a functional fiber produced therefrom
#17Controlled release oral pharmaceutical dosage forms comprising MGBG
#18Nitrogen-containing ligands and their use in atomic layer deposition methods
#19Lipids and compositions for intracellular delivery of biologically active compounds
#203-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS
#21Synthesis of triethylenetetramines
#22Polyetheramines based on 1,3-dialcohols
#23Amine compound and ionic conductive agent, and electroconductive resin composition
#24Lipids and compositions for intracellular delivery of biologically active compounds
#25Controlled release oral pharmaceutical dosage forms comprising MGBG
#26Lipids and compositions for intracellular delivery of biologically active compounds
#27Lipids and compositions for intracellular delivery of biologically active compounds
#28METHODS AND COATINGS FOR TREATING BIOFILMS
#29METHODS AND COMPOSITIONS FOR TREATING BIOFILMS
#30Synthesis of triethylenetetramines
#31Bisamineazaallylic ligands and their use in atomic layer deposition methods
#32Lipids and compositions for intracellular delivery of biologically active compounds
#33Delayed release oral pharmaceutical dosage forms comprising MGBG
#34Use of nitrogen-containing ligands in atomic layer deposition methods
#35Bisamineazaallylic ligands and their use in atomic layer deposition methods
#36Synthesis of triethylenetetramines
#37NOVEL FULLERENE CYCLOPROPANATION REACTION
#38METHOD FOR PRODUCING AMINES FROM GLYCERIN
#39Synthesis of triethylenetetramines
#40Production method for ethyleneamine mixtures
#41LFA-1 Inhibitors and Use Thereof
#42NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#43NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#44Lfa-1 inhibitors and use thereof
#45Synthesis of triethylenetetramines
#46Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
#47Composition, synthesis and therapeutic applications of polyamines